1-(2-Amino-1,3-thiazol-5-yl)ethan-1-one hydrochloride

Catalog No.: 
ACBFGK719
CAS No.: 
1315368-82-1
Molecular Formula: 
C5H7ClN2OS
Molecular Weight: 
178.64
1-(2-Amino-1,3-thiazol-5-yl)ethan-1-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$140.00InquiryInquiry
1g95%$448.00InquiryInquiry
5g95%$2218.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Amino-1,3-thiazol-5-yl)ethan-1-one hydrochloride
IUPAC Name1-(2-aminothiazol-5-yl)ethan-1-one hydrochloride
MDL No.MFCD19382125
Molecular FormulaC5H7ClN2OS
Molecular Weight178.64
SMILESCC(C1=CN=C(N)S1)=O.[H]Cl
InChI KeyHUFIQVKVOIZQDF-UHFFFAOYSA-N
Synonym1-(2-amino-1,3-thiazol-5-yl)ethan-1-one hydrochloride
CAS No.1315368-82-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBFGK719 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8In Stock
  4. Then
  5. ACBFGK719 route product structure diagram
    ACBFGK7191315368-82-1
Inquiry

2. ACBFGK719 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBFGK719 route product structure diagram
    ACBFGK7191315368-82-1
Inquiry

3. ACBFGK719 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBFGK719 route product structure diagram
    ACBFGK7191315368-82-1
Inquiry

Comments (0)